It's How Medicine Should Be®

Translate

French German Italian Portuguese Russian

Study of Intravenous Thrombolysis Related Coagulopathy in Acute Ischemic Stroke

Clinical Trial Title: 
Prospective study on intravenous thrombolysis related coagulopathy in acute ischemic stroke.
Clinical Trial Protocol ID: 
15060802
Clinical Trial Investigator Name: 
Nicholas Osteraas, MD
Clinical Trial Protocol Description: 

Determine prevalence of IVtPA coagulopathy in acute ischemic stroke patients as defined by lab markers (fibrinogen and INR) and characterize the relationship between IVtPA coagulopathy and intracranial hemorrhage on neuroimaging in acute ischemic stroke.

Clinical Trial Eligibility Criteria: 

In order to participate you must meet the following criteria:

  • Be 18 years of age or older.
  • Have an acute ischemic stroke indicated by a CT or MRI.

You will be excluded from the study if any of the following criteria apply to you:

  • Are unable to consent to participate or do not have legal representative to consent.
  • Are unable to have blood drawn per the timing of the study protocol (4 labs drawn every 4 hours).

This is a partial list of inclusion and exclusion criteria.

Clinical Trial Area: 
Stroke and Cerebrovascular Disease
Contact Phone: 
(312) 563-2208
Contact Name: 
Tiffany Singson